Correlation Between VistaGen Therapeutics and OUTLOOK THERAPEUTICS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both VistaGen Therapeutics and OUTLOOK THERAPEUTICS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VistaGen Therapeutics and OUTLOOK THERAPEUTICS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VistaGen Therapeutics and OUTLOOK THERAPEUTICS INC, you can compare the effects of market volatilities on VistaGen Therapeutics and OUTLOOK THERAPEUTICS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VistaGen Therapeutics with a short position of OUTLOOK THERAPEUTICS. Check out your portfolio center. Please also check ongoing floating volatility patterns of VistaGen Therapeutics and OUTLOOK THERAPEUTICS.

Diversification Opportunities for VistaGen Therapeutics and OUTLOOK THERAPEUTICS

0.8
  Correlation Coefficient

Very poor diversification

The 3 months correlation between VistaGen and OUTLOOK is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and OUTLOOK THERAPEUTICS INC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OUTLOOK THERAPEUTICS INC and VistaGen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VistaGen Therapeutics are associated (or correlated) with OUTLOOK THERAPEUTICS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OUTLOOK THERAPEUTICS INC has no effect on the direction of VistaGen Therapeutics i.e., VistaGen Therapeutics and OUTLOOK THERAPEUTICS go up and down completely randomly.

Pair Corralation between VistaGen Therapeutics and OUTLOOK THERAPEUTICS

Given the investment horizon of 90 days VistaGen Therapeutics is expected to generate 0.29 times more return on investment than OUTLOOK THERAPEUTICS. However, VistaGen Therapeutics is 3.45 times less risky than OUTLOOK THERAPEUTICS. It trades about -0.07 of its potential returns per unit of risk. OUTLOOK THERAPEUTICS INC is currently generating about -0.08 per unit of risk. If you would invest  301.00  in VistaGen Therapeutics on September 30, 2024 and sell it today you would lose (44.00) from holding VistaGen Therapeutics or give up 14.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

VistaGen Therapeutics  vs.  OUTLOOK THERAPEUTICS INC

 Performance 
       Timeline  
VistaGen Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VistaGen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
OUTLOOK THERAPEUTICS INC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OUTLOOK THERAPEUTICS INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

VistaGen Therapeutics and OUTLOOK THERAPEUTICS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with VistaGen Therapeutics and OUTLOOK THERAPEUTICS

The main advantage of trading using opposite VistaGen Therapeutics and OUTLOOK THERAPEUTICS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VistaGen Therapeutics position performs unexpectedly, OUTLOOK THERAPEUTICS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OUTLOOK THERAPEUTICS will offset losses from the drop in OUTLOOK THERAPEUTICS's long position.
The idea behind VistaGen Therapeutics and OUTLOOK THERAPEUTICS INC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities